Literature DB >> 1595025

The value of operative ultrasonography in diagnosing tumor extension of carcinoma of the stomach.

I Kodama1, J Machi, M Tanaka, C Yoshida, K Hashimoto, J Takeda, T Kakegawa, B Sigel.   

Abstract

Operative ultrasonography was performed during operations to improve the accuracy of diagnosing the extent of the spread of carcinoma of the stomach in the following areas: tumor invasion in the gastric wall (31 patients), para-aortic lymph node metastasis (30 patients) and hepatic metastasis (30 patients). The over-all diagnostic accuracy rates of operative ultrasonography were 81 per cent for determining the depth of tumor invasion, 80 per cent for carcinoma of the mucosa, 70 per cent for carcinoma of the submucosa, 83 per cent for carcinoma of the proper muscle, 80 per cent for carcinoma of the subserosa and 100 per cent for carcinoma of the extraserosa. The over-all accuracy of operative ultrasonography in diagnosing para-aortic lymph node metastasis was 93 per cent. In comparison with the results of preoperative studies, the accuracy (sensitivity) of operative ultrasonography was significantly superior in diagnosing metastasis to the lymph nodes. In three of 30 operations, preoperatively unrecognized and nonpalpable (occult) hepatic metastases were identified by operative ultrasonography. Operative ultrasonography provides more accurate information regarding the spread of carcinoma of the stomach, and thus may be helpful in deciding upon the type of surgical procedure or in avoiding unnecessary tissue dissection.

Entities:  

Mesh:

Year:  1992        PMID: 1595025

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  2 in total

Review 1.  Early gastric cancer in Europe.

Authors:  S M Everett; A T Axon
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

2.  The value of in vitro ultrasonography in the intraoperative staging of gastric cancer. Blind study of 93 cases.

Authors:  G de Manzoni; A Macrì; G Borzellino; G Cordiano
Journal:  Surg Endosc       Date:  1994-07       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.